Just take a look at the healthcare sector. By all accounts, healthcare stocks should be in the dumps. The sector sold off ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a ...

The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental biologics licence ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket ...

Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus ...

The global Psoriatic Arthritis (PsA) Treatment Market is expected to grow from USD 11,973.7 million in 2024 to USD 25,375.6 ...

How intelligent technologies are transforming the biopharma industry’Life-changing interventions that have previously been ...

A new study illustrates the research journey behind the creation of Monteloeder's latest nootropic formulation Mindrevivetm.

Organic revenue growth1 of 4% driven by Care Enablement and Care DeliveryUnderlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full yearAccumulated savings ...